Cerus Endovascular promotes president Dr Steven Griffin to CEO

Cerus Endovascular has promoted Steven Griffin, Ph.D. to CEO of the company. Dr Griffin has been with Cerus since 2014 and was appointed president in 2018.

Dr Griffin was critical in assembling the current company’s team as well as creating and establishing the Contour brand internationally.

“Stephen played a vital role in helping me create and execute our strategic plan as well as navigating the various regulatory and commercial hurdles in order to achieve our current level of commercial and technical success,” Dr Sam Milstein, chairman of Cerus Endovascular’s board told the press. “Not only has Stephen been the key inventor behind all of the company’s implant product portfolio but the high regard with which he is held by his peers has been invaluable in affirming the credibility of the company’s technical and commercial platform.”

“I am truly honored to accept this role and will continue to give my 100% effort in expanding our global footprint with our portfolio of products,” stated Dr Griffin. “I continue to be excited about the potential of our products and the impact that they already have and will have on patients and their families. I am blessed to have a job I love and to work with so many incredibly smart people. My work never gets old.”

Earlier this year, Cerus Endovascular nabbed a U.S. Food and Drug Administration (FDA) nod for its 027 Micro-Catheter. Medical Product Outsourcing